WELL

Welltower Inc. operates as a healthcare-focused REIT with a market capitalization of $150.7 billion, trading near its 52-week high of $228.53 at $226.97. The systematic screening highlights an exceptionally high P/E ratio of 114.01, positioning the company at a significant premium relative to typical REIT valuations, while the P/S (TTM) of 13.64 reflects elevated market expectations embedded in current pricing.

The fundamental model indicates notable top-line momentum, with revenue YoY growth of 37.55% representing substantial expansion in the healthcare real estate portfolio. This growth trajectory translates to improving operational metrics, supported by a gross margin of 40.57%. The company demonstrates financial stability through a conservative D/E ratio of 0.47 and a current ratio of 2.01, suggesting adequate liquidity management relative to near-term obligations.

Systematic analysis identifies the following characteristics:

• Beta of 0.76 indicates lower volatility compared to broader equity markets, typical for defensive healthcare real estate exposure
• ROE of 3.51% and ROA of 2.25% reflect capital-intensive REIT economics, though modest relative to the elevated valuation multiple
• EPS growth of 15.68% YoY lags revenue expansion, signaling margin compression or increased depreciation charges
• P/B ratio of 3.06 against book value per share of $60.49 suggests substantial premium to asset replacement cost

The primary risk factor centers on valuation sustainability: the 114.01 P/E multiple creates limited margin for execution missteps or interest rate sensitivity given REIT operational leverage. Without peer comparison data, absolute valuation metrics position WELL at the upper end of healthcare REIT premium territory based on historical sector benchmarks.